Lipid peroxidation of lung surfactant due to reactive oxygen species released from phagocytes stimulated by bacteria from children with cystic fibrosis

Free Radical Research

Volumn 37, Issue 9, 2003, Pages 909-917

  Bouhafs, Rabea K L ^a   Samuelson, Anders ^a   Jarstrand, Connie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Nitrite and lipid peroxidation; Phagocytes; Pseudomonas; Reactive oxygen radicals; Surfactant

Indexed keywords

ALKENE DERIVATIVE; LIPID; LUNG SURFACTANT EXTRACT; MALONALDEHYDE; MEMBRANE LIPID; NITRIC OXIDE; NITROBLUE TETRAZOLIUM; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

AIRWAY; ANALYTICAL EQUIPMENT; ANIMAL CELL; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CHEMICAL REACTION; CHILD; CONTROLLED STUDY; HEATING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LIPID PEROXIDATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; MALE; NEUTROPHIL; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PHAGOCYTE; PSEUDOMONAS AERUGINOSA; RAT; REVIEW; STENOTROPHOMONAS MALTOPHILIA;

ADULT; ANIMALS; BURKHOLDERIA CEPACIA; CELLS, CULTURED; CHILD; CYSTIC FIBROSIS; HUMANS; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MACROPHAGES; NEUTROPHIL ACTIVATION; NEUTROPHILS; PSEUDOMONAS AERUGINOSA; PULMONARY SURFACTANTS; RATS; REACTIVE OXYGEN SPECIES; STENOTROPHOMONAS MALTOPHILIA;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA; SUIDAE;

EID: 0141727623     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/1071576031000124525     Document Type: Review

References (54)

1. Davis, P.B. (1993) "Pathophysiology of the lung disease in cystic fibrosis", In: Davis, P.B., ed, Cystic Fibrosis (Dekker, New York) pp 193-218.
2. Hodson, M.E. and Warner, J.O. (1992) "Cystic fibrosis: respiratory problems and their treatment", British Medical Bulletin 48, 931-948.
3. Puchelle, E. (2002) "Early bronchial inflammation in cystic fibrosis", Journal Societe Biologie 196, 29-35.
4. Armstrong, D., Grimwood, K. and Carzino, R. (1995) "Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis", British Medical Journal 310, 1571-1577.
5. Enhörning, G. and Holm, B.A. (1993) "Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube", Journal of Applied Physiology 74, 2922-2927.
6. Seeger, W., Grube, C., Gunther, A. and Schmidt, R. (1993) "Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations", European Respiratory Journal 6, 971-977.
7. Winklhofer-Roob, B.M. (1994) "Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance", Acta Paediatrica 83, 49-57.
8. Brown, R.K., Wyatt, H., Price, J.F. and Kelly, F.J. (1996) "Pulmonary dysfunction in CF is associated with oxidative stress", European Respiratory Journal 9, 334-339.
9. Richard, M.J., Portal, B., Meo, J., Coudray, C., Hadjian, A. and Favier, A. (1992) "Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid", Clinical Chemistry 38, 704-709.
10. Doring, G., Albus, A. and Hoiby, N. (1988) "Immunological aspects of cystic fibrosis", Chest 94, 109S-115S.
11. Holsclaw, D.S. (1993) "Cystic fibrosis and pulmonary involvement from multiple perspectives", Seminar in Respiratory Infections 7, 141-150.
12. Babior, B.M. (1984) "The respiratory burst of phagocytes", Journal of Clinical Investigation 73, 599-601.
13. Brown, R.K. and Kelly, F.J. (1994) "Role of free radicals in the pathogenesis of cystic fibrosis", Thorax 49, 738-742.
14. Sherman, M.P., Loro, M.L., Wong, V.Z. and Tashkin, D.P. (1991) "Cytokine- and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages", Journal of Protozoology 38, 234-236.
15. Larnikova, N., Drapier, J.C. and Laskin, D.L. (1993) "A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity", Journal of Leukocyte Biology 54, 322-328.
16. Roum, J.H., Buhl, R., McElvaney, N.G., Borok, Z. and Crystal, R.G. (1993) "Systemic glutathione deficiency in cystic fibrosis", Journal of Applied Physiology 75, 2419-2424.
17. Thomassen, M.J., Antal, J.M., Connors, M.J., Meeker, D.P. and Wiedemann, H.P. (1994) "Characterization of Exosurf (Surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses", American Journal of Respiratory Cell and Molecular Biology 10, 399-404.
18. Thomassen, M.J., Meeker, D.P., Antal, J.M., Connors, M.J. and Wiedemann, H.P. (1992) "Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages", American Journal of Respiratory Cell and Molecular Biology 7, 257-260.
19. Griese, M., Birrer, P. and Demirsoy, A. (1997) "Pulmonary surfactant in cystic fibrosis", European Respiratory Journal 10, 1983-1988.
20. Bouhafs, R.K.L. and Jarstrand, C. (1999) "Lipid peroxidation of lung surfactant by bacteria in vitro", Lung 177, 101-110.
21. Bouhafs, R.K.L. and Jarstrand, C. (1999) "Phagocyte-induced lipid peroxidation of lung surfactant", Pediatric Pulmonology 27, 322-327.
22. Bouhafs, R.K.L. and Jarstrand, C. (2000) "Interaction between lung surfactant and nitric oxide production by alveolar macrophages stimulated by group B streptococci", Pediatric Pulmonology 30,106-113.
23. Kista, D.L., Gilligan, P.H. and Whittierr, S. (1999) "Burkholderia, Stenotrophomonas, Ralstonia, Bervundimonas, Comamonas and Acidovax", In: Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C. and Yolken, R.H., eds, Manual of Clinical Microbiology (ASM Press, Washington DC), See also pp. 526-538, pp 517-525.
24. Bouhafs, R.K.L., Rauprich, P., Herting, E., Shröder, A., Robertson, B. and Jarstrand, C. (2000) "Direct and phagocyte-mediated lipid peroxidation of lung surfactant by group B streptococci", Lung 178, 317-329.
25. Gross, N.T., Nessa, K., Camner, P., Chinchilla, M. and Jarstrand, C. (1997) "Interaction between cryptococcus neoformans and alveolar macrophages", J Med. Vet Mycol 35, 263-269.
26. Jarstrand, C., Angelin, B. and Einarsson, K. (1979) "Decreased nitroblue tetrazolium reduction of granulocytes in type IV hyperlipoproteinemia", Journal of Laboratory and Clinical Medicine 94, 897-901.
27. 15N] nitrate in biological fluids", Analytical Biochemistry 126, 131-138.
28. Kirk, R.E. (1995) Experimental design: procedures for the behavioral sciences. Brools (Cole Publishing Company, Pacific Grove, USA).
29. Konstan, M.W., Hilliard, K.A., Norvell, T.M. and Berger, M. (1994) "Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation", American Journal of Respiratory and Critical Care Medicine 150, 448-454.
30. Stutts, M.J., Knowles, M.R., Gatzy, J.T. and Boucher, R.C. (1986) "Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium", Pediatric Research 20 1316-1320.
31. Stuart Walker, T. (1998) "Pseudomonadaceae", Microbiology (W. B. Saunders Company, Philadelphia, USA) pp 173-181.
32. Zughaier, S.M., Ryley, H.C. and Jackson, S.K. (1999) "Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor-alpha from human monocytes", Infection and Immunity 67, 1505-1507.
33. Gross, N.T., Nessa, K., Camner, P. and Jarstrand, C. (1999) "Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus", Medical Mycology 37, 151-157.
34. Pendino, K.J., Laskin, J.D., Shuler, R.L., Punjabi, C.J. and Laskin, D.L. (1993) "Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase", Journal of Immunology 151, 7196-7205.
35. Lorsbach, R.B., Murphy, W.J., Lowenstein, C.J., Snyder, S.H. and Russell, S.W. (1993) "Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide", Journal of Biological Chemistry 268, 1908-1913.
36. Lyons, C.R., Orloff, G.J. and Cunningham, J.M. (1992) "Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line", Journal of Biological Chemistry 267, 6370-6374.
37. Learn, D.B., Brestel, E.P. and Seetharama, S. (1987) "Hypochlorite scavenging by Pseudomonas aeruginosa alginate", Infection and Immunity 55, 1813-1818.
38. Simpson, J.A., Smith, S.E. and Dean, R.T. (1989) "Scavenging by alginate of free radicals released by macrophages", Free Radical Biology & Medicine 6, 347-353.
39. Goldberg, I. and Hochman, A. (1989) "Purification and characterization of a novel type of catalase from the bacterium Klebsiella pneumoniae", Biochimica et Biophysica Acta 991, 330-336.
40. Hassett, D.J., Charniga, L., Bean, K., Ohman, D.E. and Cohen, M.S. (1992) "Response of Pseudomonas aeruginosa to pyocyanin: mechanism of resistance, antioxidant defenses, and demonstration of a manganese-cofactored superoxide dismutase", Infection and Immunity 60, 328-336.
41. Warren, J.B., Loi, R., Rendell, N.B. and Taylor, G.W. (1990) "Nitric oxide is inactivated by the bacterial pigment pyocyanin", Biochemical Journal 266, 921-923.
42. Miles, P.R., Bowman, L., Rao, K.M., Baatz, J.E. and Huffman, L. (1999) "Pulmonary surfactant inhibits LPS-induced nitric oxide production by alveolar macrophages", American Journal of Physiology 276, L186-L196.
43. LaForce, F.M., Kelly, W.J. and Huber, G.L. (1973) "Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material", Am Rev Respir Dis 108, 783-790.
44. Juers, J.A., Rogers, R.M., McCurdy, J.B. and Cook, W.W. (1976) "Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material", J Clin Invest 58, 271-275.
45. O'Neill, S., Lesperance, E. and Klass, D.J. (1984) "Rat lung lavage surfactant enhances bacterial phagocytosis and intracellular killing by alveolar macrophages", Am Rev Respir Dis 130, 225-230.
46. Webb, D.S.A. and Jeska, E.L. (1986) "Enhanced luminol-dependent chemiluminescence of stimulated rat alveolar macrophages by pretreatment with alveolar lining material", J Leukocyte Biol 40, 55-64.
47. Gross, N.T., Hultenby, K., Mengerelli, S., Camner, P. and Jarstrand, C. (2000) "Lipid peroxidation by alveolar macrophages challenged with Cryptococcus neoformans, Candida albicans or Aspergillus fumigatus", Medical Mycology 38, 443-449.
48. Rubbo, H., Radi, R., Anselmi, D., Kirk, M., Barnes, S., Butler, J., Eirerich, J.P. and Freeman, B.A. (2000) "Nitric oxide reaction with lipid peroxyl radicals spares alpha-tocopherol during lipid peroxidation, Greater oxidant protection from the pair nitric oxide/alpha-tocopherol than alpha-tocopherol/ascorbate", J Biol Chem 275, 10812-10818.
49. O'Donnell, V.B. and Freeman, B.A. (2001) "Interactions between nitric oxide and lipid peroxidation pathways implication for vascular disease", Circ Res 88, 12-21.
50. Van der Vliet, A. and Cross, C.E. (2000) "Phagocyte oxidants and nitric oxide in cystic fibrosis: new therapeutic targets?", Curr Opin Pulm Med 6, 533-539.
51. Grasemann, H., van's Gravesande, K.S. Buscher, R. Knauer, N. Silverma, E.S. Palmer, L.J. Drazen, J.M. and Ratjen, F. (2003) "Endothelial nitric oxide synthase variants in cystic fibrosis lung disease", Am Respir Crit Care Med 167, 390-394.
52. -. Implications for the action of endothelium-derived relaxing factor (EDRF)", Free Radical Research Communication 10, 221-226.
53. Esterbauer, H. (1993) "Cytotoxicity and genotoxicity of lipid oxidation products", American Journal of Clinical Nutrition 57, 779S-786S.
54. Rayner, R.J., Wiseman, M.S., Cordon, S.M., Norman, D., Hiller, E.J. and Shale, D.J. (1991) "Inflammatory markers in cystic fibrosis", Respiratory Medicine 85, 139-145.